Magenta Therapeutics, Inc. Profile Avatar - Palmy Investing

Magenta Therapeutics, Inc.

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 ant…

Biotechnology
US, Cambridge [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of MGTA's Analysis
CIK: - CUSIP: 55910K108 ISIN: US55910K1088 LEI: - UEI: -
Secondary Listings
MGTA has no secondary listings inside our databases.